ZA89135B - Method of treating hematologic diseases and pharmaceutical composition to be used therefor - Google Patents

Method of treating hematologic diseases and pharmaceutical composition to be used therefor

Info

Publication number
ZA89135B
ZA89135B ZA89135A ZA89135A ZA89135B ZA 89135 B ZA89135 B ZA 89135B ZA 89135 A ZA89135 A ZA 89135A ZA 89135 A ZA89135 A ZA 89135A ZA 89135 B ZA89135 B ZA 89135B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
used therefor
hematologic diseases
treating hematologic
treating
Prior art date
Application number
ZA89135A
Other languages
English (en)
Inventor
Vernon K Jenkins
K Jenkins Vernon
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of ZA89135B publication Critical patent/ZA89135B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
ZA89135A 1988-01-11 1989-01-06 Method of treating hematologic diseases and pharmaceutical composition to be used therefor ZA89135B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14184888A 1988-01-11 1988-01-11

Publications (1)

Publication Number Publication Date
ZA89135B true ZA89135B (en) 1989-10-25

Family

ID=22497538

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89135A ZA89135B (en) 1988-01-11 1989-01-06 Method of treating hematologic diseases and pharmaceutical composition to be used therefor

Country Status (5)

Country Link
EP (1) EP0324521A3 (da)
JP (1) JPH02703A (da)
AU (1) AU614012B2 (da)
DK (1) DK5489A (da)
ZA (1) ZA89135B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88133A0 (en) * 1987-10-26 1989-06-30 Lilly Co Eli N-phenylalkylbenzamide fungicides
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
US6114357A (en) * 1995-11-13 2000-09-05 Smithkline Beecham Corporation Hemoregulatory compounds
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
DE10142878C5 (de) * 2001-09-03 2007-01-25 W.E.T. Automotive Systems Ag Heizelement mit Litzen-Kontakt
US20140005240A1 (en) 2002-05-31 2014-01-02 Alan D. Snow Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies
PT1511710E (pt) * 2002-05-31 2014-02-26 Proteotech Inc Compostos, composições e métodos para o tratamento de doenças da amiloide e sinucleínopatias tais como doença de alzheimer, diabetes do tipo 2, e doença de parkinson
DE10302452B4 (de) * 2003-01-23 2005-02-24 Aventis Pharma Deutschland Gmbh Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
MX2011004375A (es) 2008-10-23 2013-03-07 Vertex Pharma Moduladores del regulador de conductancia transmembrana de fibrosis quistica.
KR100929863B1 (ko) * 2009-05-19 2009-12-04 (주)참우엔씨 방수, 방폭, 내진 시공 방법
CN112876384A (zh) * 2021-01-20 2021-06-01 安阳市安林生物化工有限责任公司 一种除虫脲的合成工艺及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1862083A (en) * 1982-09-02 1984-03-08 Duphar International Research B.V. Tumor growth inhibitors
JPS6133176A (ja) * 1984-07-24 1986-02-17 Ishihara Sangyo Kaisha Ltd Ｎ−ニトロベンゾイル−ｎ’−ピリダジニルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する抗癌剤
JPS6193163A (ja) * 1984-10-12 1986-05-12 Ishihara Sangyo Kaisha Ltd Ｎ−ベンゾイル−ｎ′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
ES8801896A1 (es) * 1985-03-01 1988-03-01 Duphar Int Res Procedimiento para preparar derivados de urea
AU594098B2 (en) * 1985-12-11 1990-03-01 Ishihara Sangyo Kaisha Ltd. N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
ES2024444B3 (es) * 1986-03-10 1992-03-01 American Cyanamid Co Metodo para la preparacion de formulacion de pildoras gruesas de liberacion sostenida.
TR24034A (tr) * 1988-02-26 1991-02-05 Sumitomo Chemical Company Lmt Benzoilurea tuerevi bunu istihsal etmek icin usul bunu ihtiva eden intektisit,bunun reaksiyon ara maddesi ve aramaddesinin istihsal etme usulu
EP0336888A1 (de) * 1988-03-18 1989-10-11 Ciba-Geigy Ag Mittel zur Schädlingsbekämpfung
IL90266A0 (en) * 1988-05-20 1989-12-15 Ciba Geigy Ag Benzoylphenylureas

Also Published As

Publication number Publication date
AU614012B2 (en) 1991-08-15
DK5489D0 (da) 1989-01-06
AU2840889A (en) 1989-07-13
EP0324521A2 (en) 1989-07-19
DK5489A (da) 1989-07-12
JPH02703A (ja) 1990-01-05
EP0324521A3 (en) 1991-11-27

Similar Documents

Publication Publication Date Title
PH25897A (en) Anti-inflammatory skin moisturizing composition and method of preparing same
GB2215267B (en) Disposable faceshield and method of manufacture thereof
ZA898013B (en) Method of treatment for arthritic and inflammatory diseases
AU5287090A (en) Method and composition for treatment of periodontal disease
EP0421946A3 (en) 3-indolepyruvic acid derivatives their method of production and therapeutic use
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
HUT51247A (en) Process for production of aryl-zyanguananidins and medical compositions containing them
YU236989A (en) Derivatives of 2-iminobenzothiazoline and process for obtaining thereof
PT80658A (en) Process for the preparation of amino-acids and therapeutic method thereof
PH25047A (en) Method of purifying polydextrose and composition containing them
IL91202A0 (en) Method and composition for cryopreservation of tissue
HUT50167A (en) Process for production of derivatives of tetrasole and medical compositions containing them
HUT51285A (en) Process for production of healing nucleosides and medical compositions containing them
PH27533A (en) Adenosine derivative pharmaceutical composition and method of use thereof
GB2229751B (en) Gel composition and method of treatment of subterranean formation
CS597787A2 (en) Agent for animals&#39; utility increase and method of effective substances production
AU642173B2 (en) Improvements in or relating to a treatment and or a method of treating
EP0445239A4 (en) Anti-malarial composition and method of use
NZ229928A (en) Substituted cycloalkylthiazole derivatives; preparatory processes and pharmaceutical compositions to treat bronchopulmonary constrictions
HUT50764A (en) Process for production of new substituated 1-aryl-sulphonil-2-pirro-lidinones and medical compositions containing them
GB8923571D0 (en) Connecting means and method of use thereof
HUT50186A (en) Process for production of derivatives of alpha-alkyl-penicillin and medical compositions containing them
HUT49142A (en) Process for production of aspentate-transcarbamilase inhibitors and medical compositions containing them
HUT52546A (en) Process for cloning and expressing of human tissue factor
ZA86774B (en) Method of analgesic treatment and pharmaceutical compositions